…
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aids, power mobility, respiratory equipment rental, oxygen therapy services. It also provides solutions that supports patients dealing with heart and pulmonary disease, reduced mobility, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Income before tax | -10.34M | -6.65M | -2.70M | 2.21M | -9.33M |
| Net income | -10.70M | -6.76M | -2.78M | 4.84M | -6.17M |
| Selling general administrative | 91.86M | 89.23M | 5.28M | 5.49M | 47.37M |
| Selling and marketing expenses | 5.62M | 5.47M | 4.16M | 3.63M | 2.38M |
| Gross profit | 177.18M | 176.99M | 163.84M | 106.65M | 74.18M |
| Ebit | -3.60M | 0.51M | 1.09M | 10.96M | -1.80M |
| Ebitda | 48.32M | 51.07M | 55.25M | 40.40M | 20.69M |
| Depreciation and amortization | 51.92M | 50.55M | 54.16M | 29.44M | 22.49M |
| Operating income | -3.82M | 1.11M | 15.09M | 4.73M | -1.46M |
| Other operating expenses | 345.81M | 244.80M | 206.56M | 122.06M | 95.72M |
| Interest expense | 12.63M | 7.17M | 6.61M | 2.08M | 1.85M |
| Tax provision | - | 0.11M | - | -1.90M | -3.15M |
| Interest income | - | 6.65M | - | 1.83M | 4.28M |
| Extraordinary items | - | - | - | - | 0.00M |
| Income tax expense | 0.34M | 0.11M | 0.09M | -1.90M | -3.15M |
| Total revenue | 343.09M | 245.91M | 221.74M | 139.86M | 102.35M |
| Total operating expenses | 181.00M | 175.88M | 148.67M | 88.85M | 67.54M |
| Cost of revenue | 68.18M | 68.92M | 57.90M | 33.21M | 28.17M |
| Total other income expense net | -6.52M | -7.77M | -11.27M | -13.51M | -13.97M |
| Net income applicable to common shares | - | -6.76M | - | 4.84M | -6.17M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Total assets | 425.45M | 247.25M | 247.41M | 132.21M | 108.57M |
| Intangible assets | 107.92M | 67.95M | 74.04M | 28.89M | 14.87M |
| Other current assets | 17.13M | - | 3.83M | - | - |
| Total liab | 269.48M | 140.06M | 136.29M | 52.67M | 49.95M |
| Total stockholder equity | 139.69M | 107.19M | 111.11M | 79.55M | 58.62M |
| Other current liab | 37.66M | - | -27.10M | - | - |
| Common stock | - | 0.00M | 247.53M | 214.25M | 203.48M |
| Retained earnings | -252.22M | -170.57M | -163.81M | -161.02M | -165.86M |
| Good will | 85.65M | 50.73M | 52.83M | 28.21M | 12.46M |
| Other assets | - | 0.34M | - | 0.09M | 0.50M |
| Cash | 17.97M | 16.17M | 17.21M | 8.52M | 34.61M |
| Total current liabilities | 103.95M | 60.85M | 60.57M | 41.74M | 32.74M |
| Current deferred revenue | 4.59M | - | 4.51M | - | - |
| Net debt | 147.32M | - | 80.75M | - | - |
| Short term debt | 23.27M | 0.00M | 22.59M | 0.00M | 0.00M |
| Short long term debt total | 118.79M | - | 97.96M | - | - |
| Other stockholder equity | 391.91M | - | 27.39M | - | - |
| Property plant equipment | - | 53.86M | - | 33.50M | 23.51M |
| Total current assets | 109.01M | 73.05M | 65.43M | 41.54M | 57.23M |
| Net receivables | 48.28M | 29.12M | 48.22M | 16.38M | 11.94M |
| Long term debt | - | 64.60M | - | 3.73M | 12.30M |
| Inventory | 25.64M | 20.85M | 18.41M | 15.59M | 9.25M |
| Accounts payable | 38.43M | - | 60.57M | - | - |
| Non currrent assets other | 57.04M | - | 1.71M | - | - |
| Non current assets total | 316.43M | - | 181.97M | - | - |
| Long term debt total | - | 77.88M | - | 10.93M | 17.08M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Total cashflows from investing activities | -46.07M | -10.31M | - | -42.49M | -17.84M |
| Total cash from financing activities | -10.85M | -26.15M | 50.87M | -9.85M | 3.91M |
| Net income | -10.70M | -6.76M | -2.78M | 4.84M | -6.17M |
| Change in cash | -3.88M | -1.03M | 8.69M | -26.10M | 5.38M |
| Begin period cash flow | 21.85M | 17.21M | 8.52M | 34.61M | 29.23M |
| End period cash flow | 17.97M | 16.17M | 17.21M | 8.52M | 34.61M |
| Total cash from operating activities | 52.71M | 35.38M | 40.54M | 26.34M | 18.69M |
| Depreciation | 51.92M | 50.55M | 40.16M | 23.04M | 17.79M |
| Other cashflows from investing activities | -11.89M | 0.21M | - | -33.33M | -12.79M |
| Change to inventory | -3.38M | -3.42M | -0.06M | -2.42M | -0.04M |
| Change to account receivables | 3.60M | -3.29M | -3.06M | -0.20M | -8.82M |
| Sale purchase of stock | -0.18M | 0.57M | -1.82M | 0.57M | 19.08M |
| Other cashflows from financing activities | -0.11M | -0.65M | 63.42M | 10.79M | 17.80M |
| Capital expenditures | 17.27M | 10.31M | 6.79M | 8.97M | 5.05M |
| Change in working capital | -1.51M | -7.65M | -1.95M | 0.76M | -8.88M |
| Stock based compensation | 4.04M | 2.48M | 5.28M | 5.49M | 4.95M |
| Other non cash items | 8.88M | -3.58M | -0.26M | -5.88M | 14.80M |
| Free cash flow | 35.43M | 25.07M | 33.75M | 17.38M | 13.65M |
Sector: Healthcare Industry: Medical Distribution
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| QIPT Quipt Home Medical Corp. |
0.02 0.40% |
4.98 | - | 56.50 | 0.88 | 1.57 | 1.07 | 5.46 |
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and sleep apnea and pap treatment, home ventilation, equipment solutions, daily and ambulatory aids, power mobility, respiratory equipment rental, oxygen therapy services. It also provides solutions that supports patients dealing with heart and pulmonary disease, reduced mobility, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
| Name | Title | Year Born |
|---|---|---|
| Mr. Gregory J. Crawford | Chairman, President & CEO | NA |
| Mr. Hardik Mehta | Chief Financial Officer | NA |
| Mr. David Bachelder | Executive Vice President of Operations | NA |
| Mr. William Todd Zehnder | Chief Strategy Officer & Investor Relations | 1975 |
| Cole Stevens | VP of Corporate Development & VP of Investor Relations | NA |
| Mr. Mark Miles | Vice President of Information Technology | NA |
| Mr. Thomas W. Roehrig | Executive Vice President of Finance | 1966 |
| Patrick Dennis Gamble | Executive Vice President of Operations | NA |
| Mr. Robert Grossman LLB | Corporate Secretary | 1974 |
| Mr. Gregory J. Crawford | Chairman, President & CEO | 1974 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.